Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

JAGSONPAL PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 22.0218.3016.1727.996.60

What is the latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS is 22.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202522.02
Mar202418.30
Mar202316.17
Mar202227.99
Mar20216.60

How is EV/Core EBITDA of JAGSONPAL PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 22.02
20.33
Mar2024 18.3
13.17
Mar2023 16.17
-42.23
Mar2022 27.99
324.09
Mar2021 6.6 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,229.1 Cr 0.4% 6.4% -17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

0.4%

6.4%

-17.2%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses